|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Feb―01 |
Shared genes and relevant potential molecular linkages between COVID-19 and chronic thromboembolic pulmonary hypertension (CTEPH) |
Qianqian Li, Xia Shi, Yang Tang, Yi Fu, Xing Fu |
2 |
[GO] |
2024―Nov―15 |
Impact of antiplatelets, anticoagulants and cyclic nucleotide stimulators on neutrophil extracellular traps (NETs) and inflammatory markers during COVID-19 |
José D. Oliveira, Gislaine Vieira-Damiani, Letícia Q. da Silva, Guilherme R. Leonardi, Camila O. Vaz, Bruna C. Jacintho-Robison, et al. (+4) Bruna M. Mazetto, Erich V. de Paula, Fabíola Z. Monica, Fernanda A. Orsi |
3 |
[GO] |
2024―Nov―04 |
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management |
Luis Del Carpio-Orantes |
4 |
[GO] |
2024―Aug―26 |
The potential role of factor XI inhibitors in managing long COVID |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam |
5 |
[GO] |
2024―Aug―23 |
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management |
Richard C. Becker, Udaya S. Tantry, Muhammad Khan, Paul A. Gurbel |
6 |
[GO] |
2024―Aug―16 |
COVID-19 vaccination and short-term anti-coagulation levels in warfarin treatment: correspondence |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
7 |
[GO] |
2024―Jul―30 |
Comparative analysis of COVID-19-associated venous thromboembolism outcomes: evolution from 2020 to 2021-2022 |
Francisco Galeano-Valle, Pablo Demelo-Rodríguez, Rubén Alonso-Beato, José María Pedrajas, José Luis Fernández-Reyes, Romain Chopard, et al. (+4) Parham Sadeghipour, Jana Hirmerova, Behnood Bikdeli, Manuel Monreal |
8 |
[GO] |
2024―Jul―27 |
Enhanced thrombin generation induced by extracellular vesicles from severe COVID-19 cases |
Bárbara Gomes Barion, Renata de Freitas Saito, Tania Rubia Flores da Rocha, Thaís Dourado Reis Nóbrega, Erica Okazaki, Yeh-Li Ho, et al. (+3) Paula Ribeiro Villaça, Vanderson Geraldo Rocha, Fernanda Andrade Orsi |
9 |
[GO] |
2024―Jul―09 |
SARS-CoV-2 spike protein potentiates platelet aggregation via upregulating integrin αIIbβ3 outside-in signaling pathway |
Ruijie Wang, Zezhong Tian, Meiyan Zhu, Bingying Zhang, Yanzhang Li, Yiqi Zheng, et al. (+3) Yuheng Mao, Yimin Zhao, Yan Yang |
10 |
[GO] |
2024―May―18 |
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial |
Pedro Gabriel Melo de Barros e Silva, Remo H. M. Furtado, Mariana Silveira de Alcântara Chaud, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, et al. (+42) Lilian Mazza Barbosa, Mayra Akimi Suiama, Eduardo Ramacciotti, Priscilla de Aquino Martins, Aryadne Lyrio de Oliveira, Vinicius Santana Nunes, Luiz Eduardo Fonteles Ritt, Ana Thereza Rocha, Lucas Tramujas, Sueli V. Santos, Dario Rafael Abregu Diaz, Lorena Souza Viana, Lívia Maria Garcia Melro, Estêvão Lanna Figueiredo, Fernando Carvalho Neuenschwander, Marianna Deway Andrade Dracoulakis, Rodolfo Godinho Souza Dourado Lima, Vicente Cés de Souza Dantas, Anne Cristine Silva Fernandes, Otávio Celso Eluf Gebara, Mauro Esteves Hernandes, Diego Aparecido Rios Queiroz, Viviane C. Veiga, Manoel Fernandes Canesin, Leonardo Meira de Faria, Gilson Soares Feitosa-Filho, Marcelo Basso Gazzana, Idelzuíta Leandro Liporace, Aline de Oliveira Twardowsky, Lilia Nigro Maia, Flávia Ribeiro Machado, Alexandre de Matos Soeiro, Germano Emílio Conceição-Souza, Luciana Armaganijan, Patrícia O. Guimarães, Regis G. Rosa, Luciano C. P. Azevedo, John H. Alexander, Alvaro Avezum, Otávio Berwanger, Alexandre B. Cavalcanti, Renato D. Lopes |
11 |
[GO] |
2024―May―09 |
Protein C and S activities in COVID-19: A systematic review and meta-analysis |
Zahra Khoshnegah, Payam Siyadat, Mehrdad Rostami, Maryam Sheikhi, Mohammad Ghorbani, Hassan Mansouritorghabeh |
12 |
[GO] |
2024―Apr―26 |
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis |
Cho-Han Chiang, Omer Ahmed, Weitao Liu, Xin Ya See, Yu-Cheng Chang, Chun-Yu Peng, et al. (+4) Zihan Wang, Cho-Hsien Chiang, Yuan Ping Hsia, Cho-Hung Chiang |
13 |
[GO] |
2024―Mar―25 |
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity |
Erica Okazaki, Bárbara Gomes Barion, Tania Rubia Flores da Rocha, Giovanna Di Giacomo, Yeh-Li Ho, Cynthia Rothschild, et al. (+6) Giancarlo Fatobene, Bruna del Guerra de Carvalho Moraes, Bianca Stefanello, Paula Ribeiro Villaça, Vanderson Geraldo Rocha, Fernanda Andrade Orsi |
14 |
[GO] |
2024―Mar―25 |
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment |
Li-Hua Liu, Yang-Zhao Zhou, Tian-Yu Li, Da-Bin Kuang, Qun Liang, Lei Chen, et al. (+3) Da-Feng Yang, Xia Zhang, Sheng-Lan Tan |
15 |
[GO] |
2023―Dec―14 |
External validation of the CHEDDAR score for suspected pulmonary embolism in patients with SARS-CoV-2 infection in an independent cohort |
Anabel Franco-Moreno, Elena Palma-Huerta, Elisa Fernández-Vidal, Elena Madroñal-Cerezo, Javier Marco-Martínez, Rodolfo Romero-Pareja, et al. (+14) Aida Izquierdo-Martínez, Lorena Carpintero-García, José Manuel Ruiz-Giardín, Juan Torres-Macho, Cristina Lucía de Ancos-Aracil, David Brown-Lavalle, Nuria Muñoz-Rivas, Eva Moya-Mateo, María Teresa Bellver-Álvarez, Ana Bustamante-Fermosel, Carmen Campos-Rebollo, María García-Lorente, Idoia Pagai-Valcárcel, Roberto Pedrero-Tomé |
16 |
[GO] |
2023―Sep―22 |
Differential platelet activation through an interaction with spike proteins of different SARS-CoV-2 variants |
Ziv Sevilya, Alona Kuzmina, Michal Cipok, Vera Hershkovitz, Danielle Keidar-Friedman, Ran Taube, Eli I. Lev |
17 |
[GO] |
2023―Aug―12 |
Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes |
Marko Lucijanic, Ivan Krecak, Iva Busic, Armin Atic, Josip Stojic, Anica Sabljic, et al. (+6) Ena Soric, Petra Veic, Sanja Marevic, Lovorka Derek, Josko Mitrovic, Ivica Luksic |
18 |
[GO] |
2023―Jul―15 |
Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials |
Muhammad Ehsan, Uzair Jafar, Momina Butt, Aiman Naveed, Mohammad Umer, Muhammad Ayyan, et al. (+2) Biah Mustafa, Rehmat Ullah Awan |
19 |
[GO] |
2023―May―23 |
Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis |
Mehrdad Rostami, Hassan Mansouritorghabeh |
20 |
[GO] |
2023―Jan―18 |
Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis |
Marco Zuin, Stefano Barco, George Giannakoulas, Matthias M Engelen, Lukas Hobohm, Luca Valerio, et al. (+4) Christophe Vandenbriele, Peter Verhamme, Thomas Vanassche, Stavros V Konstantinides |
21 |
[GO] |
2023―Jan―18 |
Thrombotic outcomes in patients in a large clinical enterprise following COVID-19 vaccination |
William M. Patterson, Brady D. Greene, Leben Tefera, James Bena, Alex Milinovich, Neil Mehta, et al. (+4) Mina K. Chung, Samir Kapadia, Lars G Svensson, Scott J. Cameron |
22 |
[GO] |
2022―Dec―24 |
Nasopharyngeal viral load at admission is not an independent predictor of thromboembolic complications in unvaccinated COVID-19 hospitalized patients. |
Narda Ontiveros, Adolfo Del Bosque-Aguirre, Mauricio Gonzalez-Urquijo, David E. Hinojosa Gonzalez, Michel Fernando Martinez-Resendez, Luis Schang, Mario Alejandro Fabiani |
23 |
[GO] |
2022―Dec―17 |
Comprehensive collection of COVID-19 related prosthetic valve failure: a systematic review |
Theresa K. Trieu, Kade Birkeland, Asher Kimchi, Ilan Kedan |
24 |
[GO] |
2022―Dec―14 |
Association between thromboembolic events and COVID-19 infection within 30 days: a case-control study among a large sample of adult hospitalized patients in the United States, March 2020-June 2021 |
Ya-Lin A. Huang, Hussain Yusuf, Alys Adamski, Joy Hsu, James Baggs, Rehab Auf, et al. (+9) Stacey Adjei, Rhett Stoney, W. Craig Hooper, Eloisa Llata, Emilia H. Koumans, Jean Y. Ko, Sebastian Romano, Tegan K. Boehmer, Aaron M. Harris |
25 |
[GO] |
2022―Nov―19 |
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis |
Xiaojie Zheng, Fangbo Gao, Le Wang, Yao Meng, Walter Ageno, Xingshun Qi |
26 |
[GO] |
2022―Nov―13 |
Targeted genetic analysis unveils novel associations between ACE I/D and APO T158C polymorphisms with D-dimer levels in severe COVID-19 patients with pulmonary embolism |
Giuseppe Fiorentino, Giuditta Benincasa, Antonietta Coppola, Monica Franzese, Anna Annunziata, Ornella Affinito, et al. (+2) Mario Viglietti, Claudio Napoli |
27 |
[GO] |
2022―Sep―19 |
Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study |
Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen, Deepa Malhotra, Birol Emir, Cristina Russ, et al. (+7) Xiaoyan Li, Theodore C. Lee, Mauricio Ferri, Danny Wiederkehr, Maya Reimbaeva, Geoffrey D. Barnes, Gregory Piazza |
28 |
[GO] |
2022―Sep―19 |
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period |
Ersan Atahan, Emine Karabul, Ruveyda Akcin, Buket Caliskaner Ozturk, Aysegul Gencer, Bekir Kocazeybek |
29 |
[GO] |
2022―Aug―03 |
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials |
Eros Pilia, Alessandro Belletti, Stefano Fresilli, Gabriele Finco, Giovanni Landoni |
30 |
[GO] |
2022―Jul―26 |
High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19 |
Monica Bray, Melda A. Guzel, Fong Lam, Andrew Yee, Miguel A. Cruz, Rolando E. Rumbaut |
31 |
[GO] |
2022―Jun―28 |
Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection |
Eileen Shiuan, Deva Sharma, E. Wesley Ely, Nikil Moodabagil, Benjamin F. Tillman |
32 |
[GO] |
2022―Jun―28 |
“Lockdown-thrombosis”-an unexpected problem of the COVID-19 pandemic? |
Chaozer Er, Jing Yuan Tan, Chuen Wen Tan, Hartirathpal Kaur, May Anne Cheong, Lai Heng Lee, Heng Joo Ng |
33 |
[GO] |
2022―Jun―10 |
Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism |
Martin R. Prince, Hreedi Dev, Elizabeth G. Lane, Daniel J. Margolis, Maria T. DeSancho |
34 |
[GO] |
2022―Jun―02 |
Metformin therapy in COVID-19: inhibition of NETosis |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
35 |
[GO] |
2022―May―17 |
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum |
Geoffrey D Barnes, Allison Burnett, Arthur Allen, Jack Ansell, Marilyn Blumenstein, Nathan P Clark, et al. (+10) Mark Crowther, William E Dager, Steven B. Deitelzweig, Stacy Ellsworth, David Garcia, Scott Kaatz, Leslie Raffini, Anita Rajasekhar, Andrea Van Beek, Tracy Minichiello |
36 |
[GO] |
2022―Apr―30 |
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study |
Steve Deitelzweig, Xuemei Luo, Jennifer L. Nguyen, Deepa Malhotra, Birol Emir, Cristina Russ, et al. (+7) Xiaoyan Li, Theodore C. Lee, Mauricio Ferri, Danny Wiederkehr, Maya Reimbaeva, Geoffrey D. Barnes, Gregory Piazza |
37 |
[GO] |
2022―Mar―04 |
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database |
Naveed Akhtar, Fatma Abid, Rajvir Singh, Saadat Kamran, Yahia Imam, Salman Al Jerdi, et al. (+8) Sarah Salameh, Rand Al Attar, Muhammad Yasir, Hammad Shabir, Deborah Morgan, Sujatha Joseph, Muna AlMaslamani, Ashfaq Shuaib |
38 |
[GO] |
2022―Feb―14 |
A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines |
Mostafa H. Elberry, Hussien Ahmed H. Abdelgawad, Aboalmagd Hamdallah, Walid Shaban Abdella, Ahmed Sayed Ahmed, Hazem S. Ghaith, Ahmed Negida |
39 |
[GO] |
2022―Feb―03 |
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study-Reply to comment from Muzaffar et al. |
Bingwen Eugene Fan, Yew Woon Chia, Gek Hsiang Lim, Chwee Fang Bok, Shiun Woei Wong |
40 |
[GO] |
2022―Jan―29 |
Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study |
Shaojun Jiang, Meina Lv, Zhiwei Zeng, Zongwei Fang, Mingrong Chen, Jiafen Qian, et al. (+3) Tingting Wu, Wenjun Chen, Jinhua Zhang |
41 |
[GO] |
2022―Jan―18 |
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes |
Abira Usman, Kevin P. Bliden, Alastair Cho, Naval Walia, Christophe Jerjian, Arvind Singh, et al. (+4) Parshotam Kundan, Sanchit Duhan, Udaya S. Tantry, Paul A. Gurbel |
42 |
[GO] |
2021―Dec―14 |
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease |
Nadine Gauchel, Marina Rieder, Krystin Krauel, Isabella Goller, Maren Jeserich, Ulrich Salzer, et al. (+12) Ana Cecilia Venhoff, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, Winfried Kern, Siegbert Rieg, Hans-Jörg Busch, Maike Hofmann, Christoph Bode, Daniel Duerschmied, Achim Lother, Lukas A. Heger |
43 |
[GO] |
2021―Nov―20 |
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study |
Syed Nabeel Muzaffar, Suhail Sarwar Siddiqui, Afzal Azim |
44 |
[GO] |
2021―Nov―05 |
Brain venography performance following the pause of Ad.26.COV2.S COVID-19 vaccine administration |
Clayton V. Long, Jonathan D. Clemente, Sam Singh, Dale Strong, Jeremy B. Rhoten, Tanushree Prasad, Andrew W. Asimos |
45 |
[GO] |
2021―Nov―04 |
International COVID-19 biomarkers colloquium |
Richard C. Becker, Diana A. Gorog |
46 |
[GO] |
2021―Nov―01 |
A comprehensive review of vascular complications in COVID-19 |
Yogesh Acharya, Aqeel Alameer, Gavin Calpin, Maha Alkhattab, Sherif Sultan |
47 |
[GO] |
2021―Oct―28 |
The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury |
Giuseppe Lippi, Ivan Szergyuk, Maria Helena Santos de Oliveira, Stefanie W. Benoit, Justin L. Benoit, Emmanuel J. Favaloro, Brandon Michael Henry |
48 |
[GO] |
2021―Oct―27 |
Pulmonary embolism in patients with COVID-19 pneumonia on adequate oral anticoagulation |
Giuseppe Di Tano, Meghi Dede, Irene Pellicelli, Enrico Martinelli, Luigi Moschini, Elva Calvaruso, Gian Battista Danzi |
49 |
[GO] |
2021―Oct―23 |
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy |
Rossella Cacciola, Elio Gentilini Cacciola, Veronica Vecchio, Emma Cacciola |
50 |
[GO] |
2021―Sep―28 |
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study |
Bingwen Eugene Fan, Kollengode Ramanathan, Christina Lai Lin Sum, Dheepa Christopher, Stephrene Seok Wei Chan, Gek Hsiang Lim, et al. (+13) Chwee Fang Bok, Shiun Woei Wong, David Chien Lye, Barnaby Edward Young, Jia Yan Lim, Rui Min Lee, Shu Ping Lim, Hwee Tat Tan, Mui Kia Ang, Soon Lee Lau, Ponnudurai Kuperan, Kiat Hoe Ong, Yew Woon Chia |
51 |
[GO] |
2021―Sep―23 |
COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation |
Mohamad Raad, Sarah Gorgis, Chelsea Abshire, Monica Yost, Mohammed F Dabbagh, Omar Chehab, et al. (+8) Lindsey Aurora, Sati Patel, Paul Nona, Jerry Yan, Gurjit Singh, John Syrjamaki, Scott Kaatz, Sachin Parikh |
52 |
[GO] |
2021―Sep―22 |
Patterns of vascular access device use and thrombosis outcomes in patients with COVID-19: a pilot multi-site study of Michigan hospitals |
Jonathan Sebolt, Julian Buchinger, Sushant Govindan, Qisu Zhang, Megan O’Malley, Vineet Chopra |
53 |
[GO] |
2021―Sep―15 |
Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid |
Toshiki Kuno, Matsuo So, Mai Takahashi, Natalia N. Egorova |
54 |
[GO] |
2021―Sep―14 |
Immature platelets in patients with Covid-19: association with disease severity |
Amir Cohen, Emanuel Harari, Ella Yahud, Michal Cipok, Gabriel Bryk, Nili Karp Lador, et al. (+3) Tal Mann, Ami Mayo, Eli I. Lev |
55 |
[GO] |
2021―Sep―12 |
Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective |
Mohammed A. Abosheasha, Afnan H. El-Gowily, Abdo A. Elfiky |
56 |
[GO] |
2021―Sep―08 |
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone |
Nicola Potere, Matteo Candeloro, Ettore Porreca, Stefano Marinari, Camilla Federici, Raffaella Auciello, Marcello Di Nisio |
57 |
[GO] |
2021―Aug―26 |
One-year outcomes of patients with ST-segment elevation myocardial infarction during the COVID-19 pandemic |
Kailun Phua, Nicholas W. S. Chew, Vincent Sim, Audrey A. Zhang, Saurabh Rastogi, Pipin Kojodjojo, et al. (+18) Wei-Ping Daniel Chor, Brandon Chi-Ping Koh, Benjamin Sieu-Hon Leong, Zhe-Yan Ng, Benjamin Wei-Liang Tung, Anand Ambhore, William K. F. Kong, Kian-Keong Poh, Ping Chai, Gavin Ng, Koo-Hui Chan, Chi-Hang Lee, Joshua Ping-Yun Loh, Adrian Fatt-Hoe Low, Mark Yan-Yee Chan, Tiong-Cheng Yeo, Huay-Cheem Tan, Poay-Huan Loh |
58 |
[GO] |
2021―Aug―19 |
Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19 |
Julie E. Farrar, Toby C. Trujillo, Scott W. Mueller, Lyra Beltran, Cecilia Nguyen, Kathryn Hassell, Tyree H. Kiser |
59 |
[GO] |
2021―Aug―17 |
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor’s page series |
Richard C. Becker |
60 |
[GO] |
2021―Aug―04 |
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles |
Richard C. Becker, Travis Sexton, Susan Smyth |
61 |
[GO] |
2021―Jul―16 |
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study) |
Luis García de Guadiana-Romualdo, Daniel Morell-García, Emmanuel J. Favaloro, Juan A. Vílchez, Josep M. Bauça, María J. Alcaide Martín, et al. (+53) Irene Gutiérrez Garcia, Patricia de la Hera Cagigal, José Manuel Egea-Caparrós, Sonia Pérez Sanmartín, José I. Gutiérrez Revilla, Eloísa Urrechaga, Jose M. Álamo, Ana M. Hernando Holgado, María-Carmen Lorenzo-Lozano, Magdalena Canalda Campás, María A. Juncos Tobarra, Cristian Morales-Indiano, Isabel Vírseda Chamorro, Yolanda Pastor Murcia, Laura Sahuquillo Frías, Laura Altimira Queral, Elisa Nuez-Zaragoza, Juan Adell Ruiz de León, Alicia Ruiz Ripa, Paloma Salas Gómez-Pablos, Iria Cebreiros López, Amaia Fernández Uriarte, Alex Larruzea, María L. López Yepes, Natalia Sancho-Rodríguez, María C. Zamorano Andrés, José Pedregosa Díaz, Luis Sáenz, Clara Esparza del Valle, María C. Baamonde Calzada, Sara García Muñoz, Marina Vera, Esther Martín Torres, Silvia Sánchez Fdez-Pacheco, Luis Vicente Gutiérrez, Laura Jiménez Añón, Alfonso Pérez Martínez, Aurelio Pons Castillo, Ruth González Tamayo, Jorge Férriz Vivancos, Olaia Rodríguez-Fraga, Vicens Díaz-Brito, Vicente Aguadero, M. G. García Arévalo, María Arnaldos Carrillo, Mercedes González Morales, María Núñez Gárate, Cristina Ruiz Iruela, Patricia Esteban Torrella, Martí Vila Pérez, Cristina Acevedo Alcaraz, Alfonso L. Blázquez-Manzanera, Amparo Galán Ortega |
62 |
[GO] |
2021―Jul―14 |
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19 |
Junko Ichikawa, Ryouta Okazaki, Tomoki Fukuda, Takuya Ono, Motonao Ishikawa, Makiko Komori |
63 |
[GO] |
2021―Jul―13 |
Venous and arterial thromboembolic disease in COVID-19 |
J. ten Berg |
64 |
[GO] |
2021―Jul―02 |
U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients |
Toshiki Kuno, Matsuo So, Mai Takahashi, Natalia N. Egorova |
65 |
[GO] |
2021―Jun―26 |
Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection |
Maurizio Fattorutto, Yves Bouckaert, Jonathan Brauner, Stéphane Franck, Fabrice Bouton, Danielle Heuse, et al. (+2) Charlotte Bouckaert, Arnaud Bruyneel |
66 |
[GO] |
2021―Jun―23 |
Routine screening for pulmonary embolism in COVID-19 patients at the emergency department: impact of D-dimer testing followed by CTPA |
Daniël A. Korevaar, Ilayda Aydemir, Maartje W. Minnema, Kaoutar Azijli, Ludo F. Beenen, Jarom Heijmans, et al. (+8) Nick van Es, Mohanad al Masoudi, Lilian J. Meijboom, Saskia Middeldorp, Prabath W. Nanayakkara, Rick I. Meijer, Peter I. Bonta, Josien van Es |
67 |
[GO] |
2021―Jun―19 |
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 |
Mark Goldin, Stephanie K. Lin, Nina Kohn, Michael Qiu, Stuart L. Cohen, Matthew A. Barish, et al. (+11) Eugenia Gianos, Anise Diaz, Safiya Richardson, Dimitrios Giannis, Saurav Chatterjee, Kevin Coppa, Jamie S. Hirsch, Sam Ngu, Sheila Firoozan, Thomas McGinn, Alex C. Spyropoulos |
68 |
[GO] |
2021―Jun―17 |
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19 |
Mariana Corrochano, René Acosta-Isaac, Sergi Mojal, Sara Miqueleiz, Diana Rodriguez, María Ángeles Quijada-Manuitt, et al. (+7) Edmundo Fraga, Marta Castillo-Ocaña, Kristopher Amaro-Hosey, Nil Albiol, José Manuel Soria, Rosa Maria Antonijoan, Joan Carles Souto |
69 |
[GO] |
2021―Jun―10 |
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 |
Marco G. Mennuni, Roberta Rolla, Leonardo Grisafi, Enrico G. Spinoni, Andrea Rognoni, Veronica Lio, et al. (+10) Luigi M. Castello, Pier P. Sainaghi, Mario Pirisi, Gian Carlo Avanzi, Marco Krengli, Mattia Bellan, Daniela Ferrante, Gianluca Aimaretti, Umberto Dianzani, Giuseppe Patti |
70 |
[GO] |
2021―Jun―02 |
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19 |
Oktay Gülcü, Emrah Aksakal, Selim Aydemir, Remziye Doğan, İbrahim Saraç, Sidar Şiyar Aydın, et al. (+4) Mustafa Öztürk, Uğur Aksu, Kamuran Kalkan, İbrahim Halil Tanboğa |
71 |
[GO] |
2021―Jun―01 |
Prior use of anticoagulation is associated with a better survival in COVID-19 |
A. G. Buenen, Marijn Sinkeldam, Martje L. Maas, Martha Verdonschot, Peter C. Wever |
72 |
[GO] |
2021―May―29 |
Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry) |
Tuncay Kiris, Eyüp Avci, Tuba Ekin, Didar Elif Akgün, Mücahit Tiryaki, Arafat Yidirim, et al. (+14) Kutluhan Hazir, Bektaş Murat, Mehtap Yeni, Rojhad Altindag, Sefa Gül, Baran Arik, Tuncay Güzel, Selda Murat, Ahmet Oz, Mustafa Karabacak, Zihni Aktas, Tarik Yildirim, Baris Kilicaslan, Asim Oktay Ergene |
73 |
[GO] |
2021―May―28 |
Incidence of thrombotic complications in COVID-19 |
William J. Jenner, Diana A. Gorog |
74 |
[GO] |
2021―May―28 |
Transient endothelial injury and release of lupus anticoagulant in COVID-19 |
Antonin Trimaille, Benjamin Marchandot, Walid Oulehri, Adrien Carmona, Olivier Vollmer, Vincent Poindron, et al. (+6) Kensuke Matsushita, Laurent Sattler, Lelia Grunebaum, Anne-Sophie Korganow, Valerie Schini-Kerth, Olivier Morel |
75 |
[GO] |
2021―May―28 |
Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection |
Salwa A. Koubaissi, Michella Abi Zeid Daou, Rayan Mohamad, Ahmad Husari |
76 |
[GO] |
2021―May―22 |
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests |
Paul A. Gurbel, Udaya S. Tantry, Robert F. Storey |
77 |
[GO] |
2021―May―21 |
Screening for venous thromboembolism in patients with COVID-19 |
Christophe Vandenbriele, Diana A. Gorog |
78 |
[GO] |
2021―May―14 |
Venous thromboembolism in non-COVID-19 population during the pandemic: a nationwide multicenter retrospective survey |
Cheng Qian, Xiao Lyu, Hai-Dong Zhu, Yi Zhang, Rui-Jie Du, Rui Li, et al. (+2) Gao-Jun Teng, Jian-Ping Gu |
79 |
[GO] |
2021―May―12 |
ICODE: the international COVID-19 thrombosis biomarkers colloquium-novel soluble biomarkers: circulating cell-free nucleic acids and other molecules |
Krystin Krauel, Daniel Duerschmied |
80 |
[GO] |
2021―May―10 |
Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon? |
Vittorio Pavoni, Lara Gianesello, Andrew Horton |
81 |
[GO] |
2021―May―08 |
The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study |
Matsuo So, David J. Steiger, Mai Takahashi, Natalia N. Egorova, Toshiki Kuno |
82 |
[GO] |
2021―May―03 |
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
Daniel L. Eisenson, Oluwafemi P. Owodunni, Brandyn D. Lau, Mujan Varasteh Kia, Peggy S. Kraus, Christine G. Holzmueller, et al. (+3) Dauryne L. Shaffer, Michael B. Streiff, Elliott R. Haut |
83 |
[GO] |
2021―Apr―28 |
Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation |
Elvira Grandone, Giovanni Tiscia, Raffaele Pesavento, Antonio De Laurenzo, Davide Ceccato, Maria Teresa Sartori, et al. (+9) Lucia Mirabella, Gilda Cinnella, Mario Mastroianno, Lidia Dalfino, Donatella Colaizzo, Roberto Vettor, Mariano Intrieri, Angelo Ostuni, Maurizio Margaglione |
84 |
[GO] |
2021―Apr―28 |
Massive intraperitoneal hemorrhage in patients with COVID-19: a case series |
Vahid Reisi-Vanani, Zahra Lorigooini, Mohamad Ali Dayani, Mehrandokht Mardani, Fereidoun Rahmani |
85 |
[GO] |
2021―Apr―26 |
Impact of the pandemic of COVID-19 on emergency attendance for stroke and acute myocardial infarction in Beijing, China |
Yiqun Wu, Fei Chen, Zhaobin Sun, Yingxian Zhang, Yafang Song, Wuwei Feng, et al. (+3) Yuping Wang, Ying Liu, Haiqing Song |
86 |
[GO] |
2021―Apr―22 |
Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore |
Angelo Porfidia, Enrica Porceddu, Rosa Talerico, Massimo Montalto, Francesco Landi, Roberto Pola |
87 |
[GO] |
2021―Apr―22 |
Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid |
Diana Paredes-Ruiz, Covadonga Gómez-Cuervo, Carlos Gómez-Martín, Ángel Sánchez-Guerrero, Jesús González-Olmedo, Flora López-López, et al. (+8) Mateo Bover-Larroya, Ramón Yarza-Barrio, Diego Dimas Jara-Casas, Alicia Castelo-Laureiro, Yolanda Revilla-Ostolaza, Luis Paz-Ares, Carlos Lumbreras-Bermejo, Carmen Díaz-Pedroche |
88 |
[GO] |
2021―Apr―17 |
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19 |
A Marco, P Marco |
89 |
[GO] |
2021―Apr―12 |
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation |
Elvira Grandone, Giovanni Tiscia, Raffaele Pesavento, Antonio De Laurenzo, Davide Ceccato, Maria Teresa Sartori, et al. (+9) Lucia Mirabella, Gilda Cinnella, Mario Mastroianno, Lidia Dalfino, Donatella Colaizzo, Roberto Vettor, Mariano Intrieri, Angelo Ostuni, Maurizio Margaglione |
90 |
[GO] |
2021―Apr―12 |
Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson’s syndrome |
Luca Roncati, Lorenzo Corsi, Giuseppe Barbolini |
91 |
[GO] |
2021―Apr―07 |
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography |
Cheryl L. Maier, Tania Sarker, Fania Szlam, Roman M. Sniecinski |
92 |
[GO] |
2021―Apr―07 |
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population |
Paul A. Gurbel, Kevin P. Bliden, Amit Rout, Nicole Rapista, Naval Walia, Rahul Chaudhary, et al. (+4) Gordon Ens, Malina Traianova, Jaime S. Barnes, Udaya S. Tantry |
93 |
[GO] |
2021―Apr―04 |
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis |
Chia Siang Kow, Syed Shahzad Hasan |
94 |
[GO] |
2021―Apr―01 |
Acute limb ischemia in a patient with Covid-19 pneumonia: a case report |
Ulfah Kartikasari, Susanthy Djajalaksana, Heny Martini |
95 |
[GO] |
2021―Mar―31 |
Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports |
Merzouk Fatimazahra, Mahassine El Harras, Ilham Bensahi, Meriem Kassimi, Sara Oualim, Amal Elouarradi, et al. (+2) Salma Abdeladim, Mohamed Sabry |
96 |
[GO] |
2021―Mar―17 |
CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients |
Ramazan Gunduz, Bekir Serhat Yildiz, Ibrahim Halil Ozdemir, Nurullah Cetin, Mehmet Burak Ozen, Eren Ozan Bakir, et al. (+2) Su Ozgur, Ozgur Bayturan |
97 |
[GO] |
2021―Mar―12 |
Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients? |
Ahmet Kagan As, Burak Erdolu, Burak Duman, Elif Yazgan, Cuneyt Eris, Ufuk Aydin, et al. (+3) Yusuf Ata, Ozlem Sengoren Dikis, Tamer Türk |
98 |
[GO] |
2021―Mar―09 |
Medical publishing during the COVID-19 pandemic: then and now |
Richard C. Becker, Christoph Bode |
99 |
[GO] |
2021―Mar―06 |
Outpatient management of chronic warfarin therapy at a pharmacist-run anticoagulation clinic during the COVID-19 pandemic |
Rebecca Cope, Briann Fischetti, Nourhan Eladghm, Mahy Elaskandrany, Nardine Karam |
100 |
[GO] |
2021―Mar―05 |
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 |
Dimitrios Giannis, Matthew A. Barish, Mark Goldin, Stuart L. Cohen, Nina Kohn, Eugenia Gianos, et al. (+6) Saurav Chatterjee, Martin Lesser, Kevin Coppa, Jamie S. Hirsch, Thomas McGinn, Alex C. Spyropoulos |
101 |
[GO] |
2021―Mar―01 |
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 |
Marco G. Mennuni, Giulia Renda, Leonardo Grisafi, Andrea Rognoni, Crizia Colombo, Veronica Lio, et al. (+23) Melissa Foglietta, Ivan Petrilli, Mario Pirisi, Enrico Spinoni, Danila Azzolina, Eyal Hayden, Gianluca Aimaretti, Gian Carlo Avanzi, Mattia Bellan, Vincenzo Cantaluppi, Andrea Capponi, Luigi M. Castello, Damiano D’Ardes, Francesco Della Corte, Sabina Gallina, Marco Krengli, Mario Malerba, Sante D. Pierdomenico, Paola Savoia, Patrizia Zeppegno, Pier P. Sainaghi, Francesco Cipollone, Giuseppe Patti |
102 |
[GO] |
2021―Mar―01 |
Major bleeding complications in critically ill patients with COVID-19 pneumonia |
Anne Godier, Darless Clausse, Simon Meslin, Myriame Bazine, Elodie Lang, Florian Huche, et al. (+2) Bernard Cholley, Sophie Rym Hamada |
103 |
[GO] |
2021―Mar―01 |
ST-segment elevation in patients with COVID-19: a systematic review |
Carlos Diaz-Arocutipa, Javier Torres-Valencia, Jose Saucedo-Chinchay, Cecilia Cuevas |
104 |
[GO] |
2021―Feb―19 |
Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study |
José Augusto Santos Pellegrini, Tatiana Helena Rech, Patrícia Schwarz, Ana Cláudia Tonelli de Oliveira, Tarsila Vieceli, Rafael Barberena Moraes, et al. (+2) Leo Sekine, Marina Verçoza Viana |
105 |
[GO] |
2021―Feb―18 |
Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review |
William J. Jenner, Rahim Kanji, Saeed Mirsadraee, Ying X. Gue, Susanna Price, Sanjay Prasad, Diana A. Gorog |
106 |
[GO] |
2021―Feb―01 |
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients |
Gwendolyn Ho, Jennifer R. Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai |
107 |
[GO] |
2021―Jan―30 |
Pulmonary venous thrombosis in a patient with COVID-19 infection |
Ahmed K. Pasha, Alejandro Rabinstein, Robert D. McBane |
108 |
[GO] |
2021―Jan―28 |
Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19 |
Mujan Varasteh Kia, Brandyn D. Lau, Oluwafemi P. Owodunni, Peggy S. Kraus, Christine G. Holzmueller, Deborah B. Hobson, et al. (+3) Dauryne L. Shaffer, Michael B. Streiff, Elliott R. Haut |
109 |
[GO] |
2021―Jan―27 |
COVID-19 and its sequelae: a platform for optimal patient care, discovery and training |
Richard C. Becker |
110 |
[GO] |
2021―Jan―15 |
Association of ABO blood group type with cardiovascular events in COVID-19 |
Victor Nauffal, Aditya Achanta, Samuel Z. Goldhaber, Gregory Piazza |
111 |
[GO] |
2021―Jan―15 |
SARS-CoV-2 infection and thrombotic complications: a narrative review |
Iraklis C. Moschonas, Alexandros D. Tselepis |
112 |
[GO] |
2021―Jan―03 |
A case of thrombotic thrombocytopenic purpura associated with COVID-19 |
Davide Nicolotti, Elena G. Bignami, Sandra Rossi, Antonella Vezzani |
113 |
[GO] |
2021―Jan―02 |
Awareness of thrombotic disease during lockdown: an unusual consequence of the COVID-19 pandemic |
Matthaios Speletas |
114 |
[GO] |
2021―Jan―02 |
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? |
Franco Ruberto, Antonio Chistolini, Mariaignazia Curreli, Giacomo Frati, Antonino G. M. Marullo, Giuseppe Biondi-Zoccai, et al. (+10) Massimo Mancone, Sebastiano Sciarretta, Fabio Miraldi, Francesco Alessandri, Giancarlo Ceccarelli, Francesco Barone, Cristina Santoro, Domenico Alvaro, Francesco Pugliese, Fabio M. Pulcinelli |
115 |
[GO] |
2021―Jan―02 |
Ongoing trials on COVID-19 treatments: please, don’t forget Venous Thromboembolism! |
Marco Zuin, Giovanni Zuliani, Gianluca Rigatelli, Loris Roncon |
116 |
[GO] |
2021―Jan―01 |
Pulmonary thrombosis in Covid-19: before, during and after hospital admission |
Maria Vlachou, Anja Drebes, Luciano Candilio, Deshan Weeraman, Naheed Mir, Nick Murch, et al. (+2) Neil Davies, J. Gerry Coghlan |
117 |
[GO] |
2020―Nov―17 |
Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report |
Allen Widysanto, T. D. Wahyuni, L. H. Simanjuntak, S. Sunarso, S. S. Siahaan, H. Haryanto, et al. (+3) C. O. Pandrya, R. C. A. Aritonang, C. Gunawan |
118 |
[GO] |
2020―Nov―16 |
Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic |
Kensuke Matsushita, Sebastien Hess, Benjamin Marchandot, Chisato Sato, Dinh Phi Truong, Ngoc Thanh Kim, et al. (+4) Anne Weiss, Laurence Jesel, Patrick Ohlmann, Olivier Morel |
119 |
[GO] |
2020―Nov―11 |
Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis |
Loris Roncon, Marco Zuin, Stefano Barco, Giovanni Zuliani, Stavros V Konstantinides |
120 |
[GO] |
2020―Nov―07 |
Lupus anticoagulant and mortality in patients hospitalized for COVID-19 |
Carmine Gazzaruso, Giuseppe Mariani, Carolina Ravetto, Laura Malinverni, Elena Tondelli, Maria Cerrone, et al. (+5) Vittorio Sala, Luigi Bevilacqua, Teodoro Altavilla, Adriana Coppola, Pietro Gallotti |
121 |
[GO] |
2020―Nov―07 |
Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients |
Bingwen Eugene Fan, Thirugnanam Umapathi, Karen Chua, Yew Woon Chia, Shiun Woei Wong, Glenn Wei Leong Tan, et al. (+4) Sadhana Chandrasekar, Ying Hui Lum, Shawn Vasoo, Rinkoo Dalan |
122 |
[GO] |
2020―Nov―06 |
Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease |
Domenico G. Della Rocca, Michele Magnocavallo, Carlo Lavalle, Jorge Romero, Giovanni B. Forleo, Nicola Tarantino, et al. (+6) Cristina Chimenti, Isabella Alviz, Maria T. Gamero, Mario J. Garcia, Luigi Di Biase, Andrea Natale |
123 |
[GO] |
2020―Nov―05 |
Neutrophil extracellular traps and thrombosis in COVID-19 |
Yu Zuo, Melanie Zuo, Srilakshmi Yalavarthi, Kelsey Gockman, Jacqueline A. Madison, Hui Shi, et al. (+5) Wrenn Woodard, Sean P. Lezak, Njira L. Lugogo, Jason S. Knight, Yogendra Kanthi |
124 |
[GO] |
2020―Nov―03 |
Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients |
Viviane Zotzmann, Corinna N. Lang, Tobias Wengenmayer, Xavier Bemtgen, Bonaventura Schmid, Katharina Mueller-Peltzer, et al. (+4) Alexander Supady, Christoph Bode, Daniel Duerschmied, Dawid L. Staudacher |
125 |
[GO] |
2020―Oct―24 |
COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis |
Bingwen Eugene Fan, Jensen Ng, Stephrene Seok Wei Chan, Dheepa Christopher, Allison Ching Yee Tso, Li Min Ling, et al. (+9) Barnaby Edward Young, Lester Jun Long Wong, Christina Lai Lin Sum, Hwee Tat Tan, Mui Kia Ang, Gek Hsiang Lim, Kiat Hoe Ong, Ponnudurai Kuperan, Yew Woon Chia |
126 |
[GO] |
2020―Oct―17 |
Rotational thromboelastometry results are associated with care level in COVID-19 |
Lou M. Almskog, Agneta Wikman, Jonas Svensson, Michael Wanecek, Matteo Bottai, Jan van der Linden, Anna Ågren |
127 |
[GO] |
2020―Oct―15 |
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19 |
Xin Wang, Kamal Kant Sahu, Jan Cerny |
128 |
[GO] |
2020―Oct―15 |
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 |
Vittorio Pavoni, Lara Gianesello |
129 |
[GO] |
2020―Oct―07 |
Occurrence of pulmonary embolism related to COVID-19 |
Marie Hauguel-Moreau, Mostafa El Hajjam, Quentin De Baynast, Antoine Vieillard-Baron, Anne-Sophie Lot, Thierry Chinet, et al. (+7) Hazrije Mustafic, Céline Bégué, Robert Yves Carlier, Guillaume Geri, Olivier Dubourg, Sébastien Beaune, Nicolas Mansencal |
130 |
[GO] |
2020―Oct―07 |
Filter clotting with continuous renal replacement therapy in COVID-19 |
Paul Endres, Rachel Rosovsky, Sophia Zhao, Scott Krinsky, Shananssa Percy, Omer Kamal, et al. (+13) Russel J. Roberts, Natasha Lopez, Meghan E. Sise, David J. R. Steele, Andrew L. Lundquist, Eugene P. Rhee, Kathryn A. Hibbert, C. Corey Hardin, Finnian R. Mc Causland, Peter G. Czarnecki, Walter Mutter, Nina Tolkoff-Rubin, Andrew S. Allegretti |
131 |
[GO] |
2020―Oct―04 |
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic |
Ibtihal Abdallah, Asma Eltahir, Liam Fernyhough, Ahmed El-Bardissy, Rana Ahmed, Mohammed Abdulgelil, et al. (+8) Dina Elgaily, AbdulMoqeeth Mohammed, Ameena Jassim, Loluwa Barakat, Mazen Al-Ansari, Mehak Javed, Raja Alkhawaja, Abdel-nasser Elzouki |
132 |
[GO] |
2020―Oct―04 |
Thromboelastography findings in critically ill COVID-19 patients |
Nouran Salem, Bassam Atallah, Wasim S. El Nekidy, Ziad G. Sadik, Woosup Michael Park, Jihad Mallat |
133 |
[GO] |
2020―Sep―30 |
Immature platelets in patients hospitalized with Covid-19 |
Amir Cohen, Emanuel Harari, Michal Cipok, Avishag Laish-Farkash, Gabriel Bryk, Ella Yahud, et al. (+5) Yaron Sela, Nili Karp Lador, Tal Mann, Ami Mayo, Eli I. Lev |
134 |
[GO] |
2020―Sep―26 |
Coronavirus disease 2019 (COVID-19) in patients with systemic autoimmune diseases or vasculitis: radiologic presentation |
Azadeh Eslambolchi, Leila Aghaghazvini, Ali Gholamrezanezhad, Hoda Kavosi, Amir Reza Radmard |
135 |
[GO] |
2020―Sep―24 |
Risk factors for intracerebral hemorrhage in patients with COVID-19 |
Kara R. Melmed, Meng Cao, Siddhant Dogra, Ruina Zhang, Shadi Yaghi, Ariane Lewis, et al. (+8) Rajan Jain, Seda Bilaloglu, Ji Chen, Barry M. Czeisler, Eytan Raz, Aaron Lord, Jeffrey S. Berger, Jennifer A. Frontera |
136 |
[GO] |
2020―Sep―22 |
Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability |
Lorenzo Cerruti, Francesca Boscaro, Francesco Poletto, Elena Campello, Luca Spiezia, Paolo Simioni |
137 |
[GO] |
2020―Sep―12 |
Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate |
Itsuki Osawa, Koh Okamoto, Mahoko Ikeda, Amato Otani, Yuji Wakimoto, Marie Yamashita, et al. (+8) Takayuki Shinohara, Yoshiaki Kanno, Daisuke Jubishi, Makoto Kurano, Sohei Harada, Shu Okugawa, Yutaka Yatomi, Kyoji Moriya |
138 |
[GO] |
2020―Sep―10 |
Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis |
Benjamin Kwok, Shari B. Brosnahan, Nancy E. Amoroso, Ronald M. Goldenberg, Brooke Heyman, James M. Horowitz, et al. (+5) Catherine Jamin, Akhilesh K. Sista, Deane E. Smith, Eugene Yuriditsky, Thomas S. Maldonado |
139 |
[GO] |
2020―Sep―10 |
Diagnosis, management, and outcomes of venous thromboembolism in COVID-19 positive patients: a role for direct anticoagulants? |
Charalampos Kartsios, Anand Lokare, Husam Osman, Damian Perrin, Shahzad Razaq, Namrah Ayub, et al. (+2) Bobby Daddar, Susan Fair |
140 |
[GO] |
2020―Sep―05 |
Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19 |
Seshadri Reddy Varikasuvu, Saurabh Varshney, Naveen Dutt |
141 |
[GO] |
2020―Sep―03 |
Anticipating the long-term cardiovascular effects of COVID-19 |
Richard C. Becker |
142 |
[GO] |
2020―Sep―03 |
Differentiating biochemical from clinical heparin resistance in COVID-19 |
Ton Lisman, Jecko Thachil |
143 |
[GO] |
2020―Aug―24 |
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
Fergal McGlynn, Jennifer McGrath, Chithra Varghese, Barbara Ryan, Johnny McHugh, Arabella Fahy, Helen Enright |
144 |
[GO] |
2020―Aug―20 |
Should we consider heparin prophylaxis in COVID-19 patients? a systematic review and meta-analysis |
Mohamed Abdel-Maboud, Amr Menshawy, Ahmed Elgebaly, Eshak I. Bahbah, Gehad El Ashal, Ahmed Negida |
145 |
[GO] |
2020―Aug―19 |
Impact of COVID-19 on monitoring of therapeutic unfractionated heparin |
Sarah K. Adie, Nicholas Farina |
146 |
[GO] |
2020―Aug―18 |
High prevalence of early asymptomatic venous thromboembolism in anticoagulated COVID-19 patients hospitalized in general wards |
Sylvain Le Jeune, Jaehyo Suhl, Ruben Benainous, François Minvielle, Christine Purser, Farid Foudi, et al. (+2) Ursula Warzocha, Robin Dhote |
147 |
[GO] |
2020―Aug―18 |
Anticoagulant treatment in COVID-19: a narrative review |
Vincenzo Carfora, Giorgio Spiniello, Riccardo Ricciolino, Marco Di Mauro, Marco Giuseppe Migliaccio, Filiberto Fausto Mottola, et al. (+2) Nicoletta Verde, Nicola Coppola |
148 |
[GO] |
2020―Aug―14 |
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis |
Chiara Kessler, Hans Stricker, Daniela Demundo, Luigia Elzi, Rita Monotti, Giorgia Bianchi, et al. (+13) Michael Llamas, Luca Spinedi, Davide Rossi, Alessandro Felice Chiesa, Alberto Pagnamenta, Marco Conti, Gabriele Casso, Elisa Stoira, Elisa Valenti, Giuseppe Colucci, Georg Stussi, Bernhard Gerber, Marco Previsdomini |
149 |
[GO] |
2020―Aug―13 |
In vivo demonstration of microvascular thrombosis in severe COVID-19 |
Douglas Alexandre do Espírito Santo, Anna Cristina Bertoldi Lemos, Carlos Henrique Miranda |
150 |
[GO] |
2020―Aug―13 |
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients |
Massimo Mattioli, Devis Benfaremo, Mauro Mancini, Luciano Mucci, Paola Mainquà, Antonio Polenta, et al. (+7) Patrizia Maria Baldini, Francesca Fulgenzi, Donatella Dennetta, Samuele Bedetta, Lorenzo Gasperoni, Alessandro Caraffa, Gabriele Frausini |
151 |
[GO] |
2020―Aug―12 |
Can fibrinolytic therapy be clinically useful in severe pneumonia caused by COVID-19? |
Rafael Bornstein, José Antonio Páramo |
152 |
[GO] |
2020―Aug―11 |
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019 |
Yoshihiko Ogawa, Toshihiko Nagata, Taisuke Akiyama, Koji Nishida, Junji Kumasawa, Michihiko Kohno, et al. (+2) Hisakazu Kohata, Iwao Gohma |
153 |
[GO] |
2020―Aug―06 |
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19 |
Yang Liu, Weibo Gao, Wei Guo, Yang Guo, Maojing Shi, Guiying Dong, et al. (+3) Qinggang Ge, Jihong Zhu, Jin Lu |
154 |
[GO] |
2020―Aug―05 |
Long lasting hypercoagulability after subclinical COVID-19 |
Paolo Ferroli, Chiara Villa, Andrea Ciuffi, Guido Gubertini, Morgan Broggi |
155 |
[GO] |
2020―Aug―03 |
Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis |
Syed Shahzad Hasan, Sam Radford, Chia Siang Kow, Syed Tabish Razi Zaidi |
156 |
[GO] |
2020―Jul―30 |
Concerns for management of STEMI patients in the COVID-19 era: a paradox phenomenon |
Panayotis K. Vlachakis, Anastasios Tentolouris, Ioannis Kanakakis |
157 |
[GO] |
2020―Jul―22 |
COVID-19-associated vasculitis and vasculopathy |
Richard C. Becker |
158 |
[GO] |
2020―Jul―21 |
Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic |
Benjamin Marchandot, Antonin Trimaille, Anais Curtiaud, Kensuke Matsushita, Laurence Jesel, Olivier Morel |
159 |
[GO] |
2020―Jul―16 |
COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness |
Fenghe Du, Bao Liu, Shuyang Zhang |
160 |
[GO] |
2020―Jul―16 |
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report |
Ezio Zanon, Samantha Pasca, Elena Campello, Luca Spiezia, Roberto Vettor, Paolo Simioni |
161 |
[GO] |
2020―Jul―13 |
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature |
Ying-Kiat Tan, Claire Goh, Aloysius S. T. Leow, Paul A. Tambyah, Alicia Ang, Eng-Soo Yap, et al. (+5) Tian-Ming Tu, Vijay K. Sharma, Leonard L. L. Yeo, Bernard P. L. Chan, Benjamin Y. Q. Tan |
162 |
[GO] |
2020―Jul―13 |
Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore |
Prakash R. Paliwal, Benjamin Y. Q. Tan, Aloysius S. T. Leow, Sunny Sibi, Daniel W. P. Chor, Amanda X. Y. Chin, et al. (+21) Ying-Wei Yau, Gail B. Cross, Lily Y. H. Wong, Magdalene L. J. Chia, Zhixuan Quak, Christopher Y. K. Chua, David K. K. Tang, Ei The Zune, Jennifer Hung, Yihui Goh, Mingxue Jing, Anil Gopinathan, Cunli Yang, Aftab Ahmad, Deborah X. L. Khoo, Chang-Chuan M. Lee, Raymond C. S. Seet, Vijay K. Sharma, Hock-Luen Teoh, Leonard L. L. Yeo, Bernard P. L. Chan |
163 |
[GO] |
2020―Jul―11 |
Thrombotic circuit complications during venovenous extracorporeal membrane oxygenation in COVID-19 |
Xavier Bemtgen, Viviane Zotzmann, Christoph Benk, Jonathan Rilinger, Katrin Steiner, Alexander Asmussen, et al. (+4) Christoph Bode, Tobias Wengenmayer, Sven Maier, Dawid L. Staudacher |
164 |
[GO] |
2020―Jul―09 |
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients |
Yan Zhang, Wei Cao, Wei Jiang, Meng Xiao, Yongzhe Li, Ning Tang, et al. (+5) Zhengyin Liu, Xiaowei Yan, Yongqiang Zhao, Taisheng Li, Tienan Zhu |
165 |
[GO] |
2020―Jul―09 |
Aortic thrombus in patients with severe COVID-19: review of three cases |
María de Carranza, Danilo-Eduardo Salazar, Jesús Troya, Roberto Alcázar, Cristina Peña, Esther Aragón, et al. (+3) Marta Domínguez, Juan Torres, Nuria Muñoz-Rivas |
166 |
[GO] |
2020―Jul―06 |
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory? |
Vera Paar, Bernhard Wernly, Zhichao Zhou, Lukas J. Motloch, Uta C. Hoppe, Alexander Egle, Michael Lichtenauer |
167 |
[GO] |
2020―Jul―05 |
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? |
Ritwick Mondal, Durjoy Lahiri, Shramana Deb, Deebya Bandyopadhyay, Gourav Shome, Sukanya Sarkar, et al. (+4) Sudeb R. Paria, Tirthankar Guha Thakurta, Pratibha Singla, Subhash C. Biswas |
168 |
[GO] |
2020―Jul―03 |
Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar |
Eman Alhmoud, Osama Abdelsamad, Ezeldin Soaly, Rasha El Enany, Hazem Elewa |
169 |
[GO] |
2020―Jul―02 |
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19 |
Marina Rieder, Isabella Goller, Maren Jeserich, Niklas Baldus, Luisa Pollmeier, Luisa Wirth, et al. (+7) Alexander Supady, Christoph Bode, Hans-Jörg Busch, Bonaventura Schmid, Daniel Duerschmied, Nadine Gauchel, Achim Lother |
170 |
[GO] |
2020―Jul―01 |
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis |
B. Mestre-Gómez, R. M. Lorente-Ramos, J. Rogado, A. Franco-Moreno, B. Obispo, D. Salazar-Chiriboga, et al. (+8) T. Saez-Vaquero, J. Torres-Macho, A. Abad-Motos, C. Cortina-Camarero, A. Such-Diaz, E. Ruiz-Velasco, J. Churruca-Sarasqueta, N. Muñoz-Rivas |
171 |
[GO] |
2020―Jun―30 |
DVT incidence and risk factors in critically ill patients with COVID-19 |
Shujing Chen, Dingyu Zhang, Tianqi Zheng, Yongfu Yu, Jinjun Jiang |
172 |
[GO] |
2020―Jun―29 |
Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend |
Marie Hauguel-Moreau, Rémy Pillière, Giulio Prati, Sébastien Beaune, Thomas Loeb, Simon Lannou, et al. (+5) Sophie Mallet, Hazrije Mustafic, Céline Bégué, Olivier Dubourg, Nicolas Mansencal |
173 |
[GO] |
2020―Jun―28 |
Pharmacologic therapeutic options for thromboprophylaxis in COVID-19 |
Chia Siang Kow, Syed Shahzad Hasan |
174 |
[GO] |
2020―Jun―22 |
Correction to: Heparin resistance in COVID-19 patients in the intensive care unit |
D. White, S. MacDonald, T. Bull, M. Hayman, D. de Monteverde-Robb, D. Sapsford, et al. (+5) A. Lavinio, J. Varley, A. Johnston, M. Besser, W. Thomas |
175 |
[GO] |
2020―Jun―10 |
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis |
Bilian Yu, Xin Li, Jin Chen, Mingqi Ouyang, Hong Zhang, Xinge Zhao, et al. (+7) Liang Tang, Qin Luo, Min Xu, Lizhen Yang, Guxiang Huang, Xianling Liu, Jianjun Tang |
176 |
[GO] |
2020―Jun―09 |
Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19 |
Mario Bautista-Vargas, Fabio Bonilla-Abadía, Carlos A. Cañas |
177 |
[GO] |
2020―Jun―09 |
Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients |
Estefanía Cantador, Alberto Núñez, Pilar Sobrino, Victoria Espejo, Lucía Fabia, Lydia Vela, et al. (+2) Luis de Benito, Javier Botas |
178 |
[GO] |
2020―Jun―08 |
Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report |
Susan Mohammadi, Morteza Abouzaripour, Nastaran Hesam Shariati, Mohammad Bakhtiar Hesam Shariati |
179 |
[GO] |
2020―Jun―06 |
Hyperacute multi-organ thromboembolic storm in COVID-19: a case report |
Sarah Chibane, Guillaume Gibeau, Frédéric Poulin, Pierre Tessier, Michelle Goulet, Marc Carrier, Sylvain Lanthier |
180 |
[GO] |
2020―Jun―05 |
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients |
Anna Betoule, Camille Martinet, Guillaume Gasperini, Pauline Muller, Stéphane Foucher, Patrick Benner, Aurélien Renard |
181 |
[GO] |
2020―May―31 |
The association between treatment with heparin and survival in patients with Covid-19 |
Luis Ayerbe, Carlos Risco, Salma Ayis |
182 |
[GO] |
2020―May―30 |
Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia |
Bingwen Eugene Fan, Yew Woon Chia, Christina Lai Lin Sum, Ponnudurai Kuperan, Stephrene Seok Wei Chan, Li Min Ling, et al. (+10) Glenn Wei Leong Tan, Serene Si Ning Goh, Lai Har Wong, Shu Ping Lim, Kian Guan Eric Lim, Hwee Tat Tan, Mui Kia Ang, Soon Lee Lau, Kiat Hoe Ong, Jensen Ng |
183 |
[GO] |
2020―May―30 |
Acute pulmonary embolism in COVID-19 related hypercoagulability |
Cerruti Lorenzo, Boscaro Francesca, Poletto Francesco, Campello Elena, Spiezia Luca, Simioni Paolo |
184 |
[GO] |
2020―May―25 |
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors |
Mathieu Artifoni, Gwenvael Danic, Giovanni Gautier, Pascal Gicquel, David Boutoille, François Raffi, et al. (+2) Antoine Néel, Raphaël Lecomte |
185 |
[GO] |
2020―May―22 |
Heparin resistance in COVID-19 patients in the intensive care unit |
D. White, S. MacDonald, T. Bull, M. Hayman, R. de Monteverde-Robb, D. Sapsford, et al. (+5) A. Lavinio, J. Varley, A. Johnston, M. Besser, W. Thomas |
186 |
[GO] |
2020―May―21 |
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum |
Geoffrey D. Barnes, Allison Burnett, Arthur Allen, Marilyn Blumenstein, Nathan P. Clark, Adam Cuker, et al. (+6) William E. Dager, Steven B. Deitelzweig, Stacy Ellsworth, David Garcia, Scott Kaatz, Tracy Minichiello |
187 |
[GO] |
2020―May―19 |
Toward understanding the 2019 Coronavirus and its impact on the heart |
Richard C. Becker |
188 |
[GO] |
2020―May―16 |
Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines |
Angelo Porfidia, Roberto Pola |
189 |
[GO] |
2020―May―15 |
COVID-19 update: Covid-19-associated coagulopathy |
Richard C. Becker |
190 |
[GO] |
2020―May―11 |
Sudden death due to acute pulmonary embolism in a young woman with COVID-19 |
Veli Polat, Güngör İlayda Bostancı |
191 |
[GO] |
2020―May―11 |
Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no? |
Loris Roncon, Marco Zuin, Pietro Zonzin |
192 |
[GO] |
2020―May―11 |
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia |
Vittorio Pavoni, Lara Gianesello, Maddalena Pazzi, Caterina Stera, Tommaso Meconi, Francesca Covani Frigieri |
193 |
[GO] |
2020―May―05 |
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy |
F. Burcu Belen-Apak, F. Sarıalioğlu |
194 |
[GO] |
2020―May―04 |
Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies |
Angelo Porfidia, Roberto Pola |
195 |
[GO] |
2020―Apr―27 |
Covid-19 treatment update: follow the scientific evidence |
Richard C. Becker |
196 |
[GO] |
2020―Apr―18 |
Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report |
Bo Zhou, Jianqing She, Yadan Wang, Xiancang Ma |
197 |
[GO] |
2020―Apr―03 |
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 |
Shiyu Yin, Ming Huang, Dengju Li, Ning Tang |